SFX by Ex Libris Inc.

Title:	Increased Exploratory Activity and Altered Response to LSD in Mice Lacking the 5-HT5A Receptor
Source:	Neuron [0896-6273] Grailhe, Régis yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Crowley, John J J. "Fast vesicle replenishment and rapid recovery from desensitization at a single synaptic release site." The journal of neuroscience 27.20 (2007): 5448-60.
description	2.	Thomas, David R. "5-ht5A receptors as a therapeutic target." Pharmacology & therapeutics 111.3 (2006): 707-14.
description	3.	Anton, E. "Distinct functions of alpha(3) and alpha(v) integrin receptors in neuronal migration and laminar organization of the cerebral cortex." Neuron 22.2 (1999): 277-289.
description	4.	Benjamin, C. "Persistent psychiatric symptoms after eating psilocybin mushrooms." British medical journal 1.6174 (1979): 1319-1320.
description	5.	Winter, I D D. "Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli." Psychopharmacology 22.1 (1971): 64-71.
description	6.	Rodgers, J. "Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study." Addictive Behaviors 29.4 (2004): 743-52.
description	7.	Halpern, John H. "Hallucinogen persisting perception disorder: what do we know after 50 years?" Drug and alcohol dependence 69.2 (2003): 109-19.
description	8.	Espiard, M. "Hallucinogen persisting perception disorder after psilocybin consumption: a case study." European psychiatry 20.5/6 (2005): 458-60.
description	9.	Nikiforuk, A. "The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia." Neuropharmacology 105.C (2016): 351-360.
description	10.	Hirata, Y. "Lack of association between HTR4 gene polymorphisms and schizophrenia in case-control and family-based samples." Psychiatry research (2010): 176-178.
description	11.	Kassai, F. "Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression." Behavioural pharmacology 23.4 (2012): 397-406.
description	12.	Cunningham,, K. A., K A. "Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD)." Psychopharmacology 91.1 (1987): 67-73.
description	13.	Toonen, Ruud F G F. "Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size." Proceedings of the National Academy of Sciences of the United States of America 103.48 (2006): 18332-7.
description	14.	Bogerts, B. "Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics." Neuroscience 83.3 (1998): 867-75.
description	15.	Letinic, K. "Origin of GABAergic neurons in the human neocortex." Nature 417.6889 (2002): 645-649.
description	16.	Ross, Robert S S. "Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors." Cardiovascular research 63.3 (2004): 381-90.
description	17.	Anton, P S. "Role of neuron-glial junctional domain proteins in the maintenance and termination of neuronal migration across the embryonic cerebral wall." The journal of neuroscience (1996): 2283-2293.
description	18.	Yamada, K M M. "Integrin transmembrane signaling and cytoskeletal control." Current opinion in cell biology 7.5 (1995): 681-9.
description	19.	Breitbart, A. "Psychotherapeutic Interventions at the End of Life: A Focus on Meaning and Spirituality." Canadian journal of psychiatry 49.6 (2004): 366-372.
description	20.	Smith, E. "Hallucinogenic mushrooms." Clinical pediatrics 27.2 (1988): 70-3.